CNS Expands Nasal Strip Technology to Include Horses

CNS, Inc., is developing a nasal strip that eases the breathing of horses during racing and other high-performance events, the company announced today. The strip performed as expected in an initial clinical trial at Kansas State University, and CNS plans to begin selling it during the fourth quarter of 1999.

According to the KSU test, the FLAIR(TM) equine nasal strip makes breathing easier for horses during strenuous exercise, such as racing or eventing, and can reduce exercise-induced pulmonary hemorrhage (EIPH), a common problem for horses. The company said it planned to conduct additional studies to more completely delineate the benefits of the product.

The patented, drug-free FLAIR strip, developed by two veterinarians, is attached over a horse's nasal passages, where it is held in place by a special adhesive. The strip's spring-like action holds nasal passages open to maximize air flow.

"Horses expend tremendous energy and effort simply to breathe during highly competitive events," said Daniel E. Cohen, chairman and chief executive officer of CNS. "Because the strip reduces the work of breathing, horses experience less physical stress during and after heavy exercise. The inventors of this device clearly have the welfare of the horse in mind."

"Development of the FLAIR equine nasal strip is part of our continued expansion of nasal strip technology and is consistent with the improved breathing benefit of Breathe Right(R) nasal strips," said Marti Morfitt, president and chief operating officer of CNS. She said the company expected that initial sales of the product would be through direct fulfillment and catalogs.

CNS, based in Minneapolis, designs, manufactures and markets consumer products, including the Breathe Right nasal strip. The Breathe Right strip improves breathing by reducing nasal airflow resistance. It can be effective for the temporary relief of nasal congestion due to colds and allergies, in eliminating or reducing snoring, and for the temporary relief of breathing difficulties due to a deviated nasal septum. The company also has entered into several agreements to develop and market certain new consumer products that are in various stages of evaluation and testing.

About the Author

Stephanie L. Church, Editor-in-Chief

Stephanie L. Church, Editor-in-Chief, received a B.A. in Journalism and Equestrian Studies from Averett College in Danville, Virginia. A Pony Club and 4-H graduate, her background is in eventing, and she is schooling her recently retired Thoroughbred racehorse, Happy, toward a career in that discipline. She also enjoys traveling, photography, cycling, and cooking in her free time.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners